The page is the record's research on the issuer — no analyst, no rating, no view. # Oncolys BioPharma Inc. (Growth Market: 4588) — research page As of 2026-11-06 · jp-cm-kg · record version 1 ## Identity and listing The issuer is Oncolys BioPharma Inc., listed on the Growth Market under ticker 4588. The ISIN is not on the record, and the LEI is not on the record; no GLEIF record is registered for the issuer. Its security type is Corporate, its segment is not on the record, its sector is 3250 Pharmaceutical, and its jurisdiction is Japan (EDINET domestic filer). The issuer is listed and not halted. ## The disclosure read The record holds 7 filings in the twelve months to 2026-11-06, across 4 filing days: 2 ad hoc, 3 regulatory filings and 2 results. The median gap between filing days is 91 days. The latest filing is dated 2026-11-06, is of type ad hoc, and is 0 days before the record date. The Growth Market median cadence gap is 42 days across 598 issuers, and the 3250 Pharmaceutical median is 49.5 days across 80 issuers. The Growth Market median filings is 8.0 and the sector median filings is 8.0. The Growth Market median latency is 85.0 days and the sector median latency is 85.0 days. ## Auditor The auditor of record is EY新日本有限責任監査法人. Its location is not on the record. Auditor changes are not on the record, as the market's register has no lifecycle type map yet. ## Events and halts Listing, delisting, name change, domicile change and segment move are not on the record, as the market's register has no lifecycle type map yet. The halt flag is clear: the issuer is listed, not halted. ## Orderability For the client category Qualified Institutional Investors, the outcome is not determinable. The rule states a product scope, the subject's class carries no CFI to place on the scope bridge, and no scope object names the class, so the subject is not shown within the scope. The rule version is acm-68000/jp/suitability-principle-fiea-article-40/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations pages read. The count is 0. ## Open research No openly published research notes were found on the record. The count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The market's vintage is not sealed. No issuer years are sealed, the market's earliest sealed date is not on the record, and the live record's start date is not on the record. ## Sources 7 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx (identity.exchange) - https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip (identity.jurisdiction) - https://mcp.jp-cm-kg.ai/events/TSE-GROWTH/4588 (the disclosure lines) - https://www.jpx.co.jp/markets/equities/suspended/index.html (the halt flag) - https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100XTMG (the auditor) - https://mcp.jp-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.jp-cm-kg.ai/record/TSE-GROWTH/4588 (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/jp/TSE-GROWTH/4588 · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp